FMC (FMC) Jefferies Global Industrials Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Jefferies Global Industrials Conference 2026 summary
10 Sep, 2026Market and industry outlook
Demand and supply in crop protection chemicals remain stable, with cautious inventory management and purchasing close to utilization time continuing into 2026 and early 2027.
No significant price increases are observed, except for some non-selective herbicides, with overall pricing trends stable.
The industry is experiencing cautious behavior, with no major shifts in market dynamics expected in the near term.
Strategic investments and deleveraging
Tessenderlo's investment was driven by belief in the long-term strategy, willingness to hold a 20% stake, and a three-year lockup, with no operational cooperation expected.
The investment supports deleveraging, with $1 billion proceeds used to pay down debt and a focus on stabilizing earnings from 2026 onward.
Tessenderlo's support centers on the Rynaxypyr strategy, manufacturing footprint changes, and new product growth.
Product pipeline and manufacturing
New manufacturing footprint is on track to be completed by Q1 2027, with full benefits expected in the second half of 2027.
Three key molecules—Dodhylex, Isoflex, and fluindapyr—are expected to drive growth, with major regulatory milestones and registrations anticipated in 2027 and 2028.
Core business is expected to return to growth immediately upon product line reset and repricing in late 2027.
Latest events from FMC
- Q2 2026 revenue dropped 17% and net loss widened, but asset sales aided debt reduction.FMC
Q2 2026 - Debt reduction progresses as new molecules and direct sales boost growth and confidence.FMC
Wolfe Research 3rd Annual Materials of the Future Conference 2026 - Strategic review and new product launches aim to drive growth and restore financial strength.FMC
16th Annual Wells Fargo Industrials & Materials Conference - Revenue fell 18%, key proposals split, and strategic alternatives including a sale are under review.FMC
AGM 2026 - Strategic review and financial restructuring aim to drive growth and portfolio transformation by 2027.FMC
21st Annual Global Farm to Market Conference - Q1 2026 revenue and EBITDA fell, net loss widened, but guidance and debt reduction targets held.FMC
Q1 2026 - Dirk A. Kempthorne is no longer a board nominee; all other proxy matters remain unchanged.FMC
Proxy filing - Executing asset sales, cost cuts, and licensing to drive growth and restore competitiveness.FMC
Bank of America 2026 Global Agriculture and Materials Conference - Q3 revenue up 9% and net income rebounded, with strong Americas growth and GSS sale pending.FMC
Q3 2024